Resources


PUBLISHED: 2018 CATEGORY: Health care providers TYPE: External Link Addressing vaccine hesitancy in immunization programs, clinics and practices

Addressing vaccine hesitancy in immunization programs, clinics and practices

This practice point offers evidence-based guidance for provincial/territorial immunization programs, clinics and office practices on how to address hesitancy and improve vaccine uptake rates. Steps to take include the following: 1) Detecting under-immunized subgroups (which requires record-keeping), diagnosis and targeted interventions; 2) Educating all health care workers involved with immunization on best practices; 3) Employing evidence-based strategies to increase uptake, including reminders, convenient clinic hours and locations, and tailored communication; 4) Educating children, youth and adults on the importance of immunization for health; and  5) Working collaboratively across provincial/territorial jurisdictions and with the federal government, nongovernmental organizations, community leaders and health services.

Authors: MacDonald NE and Dubé E
Corporate Authors: Canadian Paediatric Society, Infectious Diseases and Immunization Committee
Publisher: Canadian Paediatric Society

PUBLISHED: 2018 CATEGORY: Adults, New Canadians, Seniors TYPE: PDFAdult immunization : what vaccines do you need?

Adult immunization : what vaccines do you need?

Chart that shows adults how frequently they need to get certain vaccines.

Authors: Immunize Canada
Corporate Authors: Immunize Canada
Publisher: Immunize Canada

PUBLISHED: 2018 CATEGORY: Adults, Seniors, New Canadians, Travellers, Health care providers TYPE: PDFAdult immunization: What vaccines do you need?

Adult immunization: What vaccines do you need?

Corporate Authors: Immunize Canada
Publisher: Immunize Canada

PUBLISHED: 2018 CATEGORY: Health care providers TYPE: External Link Announcing the publication of the WHO immunological basis for immunization series module on influenza vaccines

Announcing the publication of the WHO immunological basis for immunization series module on influenza vaccines

In 2017, the World Health Organization (WHO) published a document aimed at facilitating influenza vaccine introduction and use in low- and middle-income countries. The document, “The Immunological Basis for Immunization Series: Influenza Vaccines”, is freely available on the WHO website. The main purpose of this document is to give immunization managers and vaccination professionals an authoritative but easily-understood overview of the scientific basis of influenza vaccination and the immunological basis for the WHO position on influenza vaccines. The influenza vaccine document comprises one module of the WHO Immunological Basis for Immunization series. The immunization community is invited to use these references; it is hoped that the influenza vaccine module will be a valuable resource for persons who manage and monitor influenza vaccine programs, particularly in low- and middle-income countries.

Authors: Ortiz JR, Hombach J
Journal Issue: 37
Journal Title: Vaccine
Journal Volume: 36
Publisher: Elsevier


PUBLISHED: 2018 CATEGORY: Health care providers TYPE: External Link Canadian Immunization Guide Chapter on Influenza and Statement on Seasonal Influenza Vaccine for 2018–2019

Canadian Immunization Guide Chapter on Influenza and Statement on Seasonal Influenza Vaccine for 2018–2019

The National Advisory Committee on Immunization (NACI): Canadian Immunization Guide Chapter on Influenza and Statement on Seasonal Influenza Vaccine for 2018–2019 updates NACI’s recommendations regarding the use of seasonal influenza vaccines.

Corporate Authors: National Advisory Committee on Immunization
Publisher: Public Health Agency of Canada

PUBLISHED: 2018 CATEGORY: Health care providers TYPE: External Link Canadian Pandemic Influenza Preparedness: Communications strategy

Canadian Pandemic Influenza Preparedness: Communications strategy

This strategy is grounded in several communications guiding principles: putting the health of Canadians first; providing timely and sound information; communicating in a coordinated fashion from across all levels of government; protecting confidentiality; and monitoring and adapting to the public’s perception of risk. The Annex outlines a risk communications approach, proposes triggers for action based on pandemics of varying impact, and includes a Communication Protocol that will be used countrywide in the event of a pandemic.

Authors: Henry B
Corporate Authors: Canadian Pandemic Influenza Preparedness Task Group
Journal Title: CCDR
Journal Volume: 44-5
Publisher: Public Health Agency of Canada

PUBLISHED: 2018 CATEGORY: Les fournisseurs de soins TYPE: External Link Chapitre sur la grippe du Guide canadien d’immunisation et Déclaration sur la vaccination antigrippale pour la saison 2018–2019

Chapitre sur la grippe du Guide canadien d’immunisation et Déclaration sur la vaccination antigrippale pour la saison 2018–2019

Le présent document, intitulé Comité consultatif national de l’immunisation (CCNI) : Chapitre sur la grippe du Guide canadien d’immunisation et Déclaration sur la vaccination antigrippale pour la saison 2018-2019, met à jour les recommandations du CCNI concernant l’utilisation de vaccins antigrippaux saisonniers.

Corporate Authors: Comité consultatif national de l'immunisation
Publisher: Agence de la santé publique du Canada

PUBLISHED: 2018 CATEGORY: Health care providers TYPE: External Link Complications of herpes zoster in immunocompetent older adults: Incidence in vaccine and placebo groups in two large phase 3 trials

Complications of herpes zoster in immunocompetent older adults: Incidence in vaccine and placebo groups in two large phase 3 trials

An adjuvanted herpes zoster (HZ) subunit vaccine, HZ/su, demonstrated high efficacy against HZ and postherpetic neuralgia (PHN) in two randomized, observer-blind, placebo-controlled trials in adults aged >50 and >70 years (ZOE-50 and ZOE-70, respectively). Data from ZOE-50 and ZOE-70 trials were analyzed to evaluate the efficacy of HZ/su against
mortality, hospitalizations, and non-PHN complications of HZ including HZ-associated vasculitis, stroke, and disseminated, ophthalmic, neurologic, and visceral diseases.

Authors: Kovac M et al.
Journal Issue: 12
Journal Title: Vaccine
Journal Volume: 36
Publisher: Elsevier

PUBLISHED: 2018 CATEGORY: Les fournisseurs de soins TYPE: External Link Contrer la réticence face à la vaccination dans les programmes de vaccination, les cliniques et les cabinets

Contrer la réticence face à la vaccination dans les programmes de vaccination, les cliniques et les cabinets

Le présent point de pratique contient des conseils fondés sur des données probantes à l’intention des programmes de vaccination provinciaux et territoriaux, des cliniques et des cabinets afin de contrer la réticence face à la vaccination et d’améliorer les taux de vaccination. Les étapes à privilégier s’établissent comme suit : 1) définir les sous-groupes sous-vaccinés (ce qui exige la tenue de registres), les facteurs responsables de la réticence face à la vaccination et les interventions ciblées; 2) enseigner les pratiques exemplaires à tous les dispensateurs de soins qui participent à la vaccination; 3) faire appel à des stratégies fondées sur des données probantes pour accroître les taux de vaccination, y compris les rappels, un emplacement des cliniques et des heures d’ouverture pratiques et des communications adaptées; 4) informer les enfants, les adolescents et les adultes de l’importance de la vaccination pour la santé et 5) travailler en collaboration avec les régions sociosanitaires provinciales et territoriales et avec le gouvernement fédéral, les organismes non gouvernementaux, les leaders communautaires et les services de santé.

Authors: MacDonald NE et Dubé E
Corporate Authors: Société canadienne de pédiatrie, Comité des maladies infectieuses et d'immunisation
Publisher: Société canadienne de pédiatrie